Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
The Journal of Endocrinology|September 3, 2016
Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitroAlejandro Ibáñez-Costa, Esther Rivero-Cortés, Mari C Vázquez-Borrego, et al.
Cancer Letters|October 10, 2020
Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinomaJuan L López-Cánovas, Mercedes Del Rio-Moreno, Helena García-Fernandez, et al.
Molecular Cancer|August 31, 2017
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessDaniel Hormaechea-Agulla, Manuel D Gahete, Juan M Jiménez-Vacas, et al.
Molecular Therapy. Nucleic Acids|March 14, 2022
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic toolVicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan M Jiménez-Vacas, et al.
Molecular Oncology|May 25, 2024
Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targetsEmilia Alors-Pérez, Ricardo Blázquez-Encinas, María Trinidad Moreno-Montilla, et al.
Ebiomedicine|March 12, 2023
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidenceAntonio C Fuentes-Fayos, Miguel E G-García, Jesús M Pérez-Gómez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2019
A Somatostatin Receptor Subtype-3 (SST<sub>3</sub>) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary TumorsMari C Vázquez-Borrego, Vandana Gupta, Alejandro Ibáñez-Costa, et al.
Acta Neuropathologica Communications|June 28, 2025
Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targetsAntonio C Fuentes-Fayos, Miguel E G-García, Teresa Sánchez-Medianero, et al.
Ebiomedicine|January 7, 2020
Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancerJuan M Jiménez-Vacas, Vicente Herrero-Aguayo, Antonio J Montero-Hidalgo, et al.
Scientific Reports|February 10, 2017
BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomasAlejandro Ibáñez-Costa, Laura M López-Sánchez, Manuel D Gahete, et al.
Pageof 15